US biotech major Biogen has presented additional results from the Phase Ib study of salanersen, an investigational novel ...

For years, AI in pharma largely remained in the innovation phase. Companies ran pilot programs, formed partnerships and ...

UK health cost watchdog the National Institute for Health and Care Excellence has issued draft guidance declining to ...

Danish biotech Commit Biologics has appointed Thomas Andresen as chief executive officer as the company prepares to move its complement-based immunotherapy platform toward the clinic.

TolerogenixX, a biopharma developing personalized cell therapies to induce sustained immune tolerance in organ ...

Russia is facing a new wave of drug shortages this year, as local media reported about the lack of supplies of anti-epilepsy ...

Belgium’s largest drugmaker UCB has announced positive topline data from the BE BOLD trial assessing Bimzelx bimekizumab) versus Skyrizi (risankizumab) in adults living with active psoriatic arthritis ...

South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has announced a collaboration agreement with US pharma major Eli Lilly to establish a Lilly Gateway Labs (LGL) ...

US biotech Capricor Therapeutics (Nasdaq: CAPR) says the US Food and Drug Administration has resumed review of its biologics license application for deramiocel to treat cardiomyopathy linked to ...

China’s Ascletis Pharma has announced positive topline results from a US Phase II, 24-week study for its subcutaneous (SC) depot formulations of small molecule GLP-1 receptor (GLP-1R) agonist ASC30 ...

UK-based cardiometabolic disease specialist George Medicines has entered into an exclusive licensing and supply agreement with South Korean pharma company Ahngook .

US clinical-stage ophthalmics company Qlaris Bio has appointed Fred Guerard as president and chief executive officer (CEO), effective March 1, 2026. He will also join the company’s board of directors.